BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1883392)

  • 1. GLP-1(7-36)amide-stimulated insulin secretion in rat islets is sodium-dependent.
    Fridolf T; Ahrén B
    Biochem Biophys Res Commun; 1991 Aug; 179(1):701-6. PubMed ID: 1883392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLP-1(7-36) amide stimulates insulin secretion in rat islets: studies on the mode of action.
    Fridolf T; Ahrén B
    Diabetes Res; 1991 Apr; 16(4):185-91. PubMed ID: 1802486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
    Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
    Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagonlike peptide I (7-37) actions on endocrine pancreas.
    Weir GC; Mojsov S; Hendrick GK; Habener JF
    Diabetes; 1989 Mar; 38(3):338-42. PubMed ID: 2645190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells.
    Miura Y; Matsui H
    Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1001-9. PubMed ID: 14534075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide.
    Heller RS; Aponte GW
    Am J Physiol; 1995 Dec; 269(6 Pt 1):G852-60. PubMed ID: 8572216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
    Gromada J; Ding WG; Barg S; Renström E; Rorsman P
    Pflugers Arch; 1997 Sep; 434(5):515-24. PubMed ID: 9242714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures.
    D'Alessio DA; Fujimoto WY; Ensinck JW
    Diabetes; 1989 Dec; 38(12):1534-8. PubMed ID: 2573553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice.
    Linn T; Schneider K; Göke B; Federlin K
    Acta Diabetol; 1996 Mar; 33(1):19-24. PubMed ID: 8777280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
    Parkes DG; Pittner R; Jodka C; Smith P; Young A
    Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that glucagon stimulates insulin secretion through its own receptor in rats.
    Kawai K; Yokota C; Ohashi S; Watanabe Y; Yamashita K
    Diabetologia; 1995 Mar; 38(3):274-6. PubMed ID: 7758872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7-36) amide on insulin release by pancreatic islets during rat ontogenic development.
    García-Flores M; Zueco JA; Alvarez E; Blázquez E
    Eur J Biochem; 2001 Feb; 268(3):514-20. PubMed ID: 11168389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas.
    Suzuki S; Kawai K; Ohashi S; Watanabe Y; Yamashita K
    Metabolism; 1992 Apr; 41(4):359-63. PubMed ID: 1556941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytosolic calcium handling in islets of normal Wistar and diabetic Goto Kakizaki rats in the presence of glucose and truncated glucagon-like peptide 1 (7-36) amide.
    Marie JC; Bailbe D
    Ann N Y Acad Sci; 2000; 921():464-8. PubMed ID: 11193877
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcitonin gene-related peptide inhibits insulin secretion studies on ion fluxes and cyclic AMP in isolated rat islets.
    Pettersson M; Ahrén B
    Diabetes Res; 1990 Sep; 15(1):9-14. PubMed ID: 1966731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glucagon like peptide-1(7-36) amide on the cytoplasmic Ca(2+)-concentration in rat islet cells.
    Fridolf T; Ahrén B
    Mol Cell Endocrinol; 1993 Oct; 96(1-2):85-90. PubMed ID: 8276143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization.
    Gromada J; Dissing S; Bokvist K; Renström E; Frøkjaer-Jensen J; Wulff BS; Rorsman P
    Diabetes; 1995 Jul; 44(7):767-74. PubMed ID: 7789644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities in glucose-stimulated insulin release, 45Ca uptake, and 86Rb efflux in diabetic Chinese hamster islets.
    Frankel BJ; Sehlin J
    Diabetes; 1987 May; 36(5):648-53. PubMed ID: 3552797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas.
    Göke R; Wagner B; Fehmann HC; Göke B
    Res Exp Med (Berl); 1993; 193(2):97-103. PubMed ID: 8516568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 (7-36 amide): a potent glucagonostatic and insulinotropic hormone.
    Matsuyama T; Komatsu R; Namba M; Watanabe N; Itoh H; Tarui S
    Diabetes Res Clin Pract; 1988 Oct; 5(4):281-4. PubMed ID: 3069410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.